Anonymous
Guest
Anonymous
Guest
Here is part of email I received yesterday:
I wanted to provide you with an update regarding my candidate selection process for the Quintiles' Project 6517 partnering with Janssen Pharmaceuticals, Inc.
This week Janssen is continuing to engage in its final analysis of their territory footprint across the country. Because Janssen remains confident that they will get FDA approval for XARELTO's second indication in just a few weeks, and because NUCYNTA ER was formally launched the week of August 29th, territory targeted universes must be properly aligned. This will serve to support the field representative team's sales objectives for two very different disease state categories. A same period, two product launch success will be greatly enhanced by the due diligence that is taking place this week to assure the most optimum alignments are finalized.
Janssen leadership has confirmed that the XARELTO National Launch Meeting is targeted for the week of November 7th.
All Quintiles recruiting activities continue across the nation, with the objective to offer employment allowing for a two week background screening process to be completed. Quintiles appreciates the professional courtesy that many of you expressed a desire to provide regarding a formal two week resignation notice.
We are gearing up for two very aggressive launch partnership strategies with Janssen.
yeah, background checks only take 48-72 hours, smoke is being blown up your asses!!!